Article
The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms.
The pharmacogenomics journal - 1 Aug 2007
Robinson J D, Lam C Y, Minnix J A, Wetter D W, Tomlinson G E, Minna J D, Chen T T-L, Cinciripini P M
Abstract excerpt
The dopamine receptor D2 (DRD2) gene has polymorphisms that have been linked to regulation of the dopamine system and to an increased prevalence of smoking. The present study examined the relationship of the DRD2 TaqI-A and -B polymorphisms with short-term clinical outcome (abstinence and withdrawal symptoms), collected from daily (14 pre-quit and 42 post-quit) diary data among smokers (n=116) treated with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
